vs
Amphastar Pharmaceuticals, Inc.（AMPH）与PLUG POWER INC（PLUG）财务数据对比。点击上方公司名可切换其他公司
PLUG POWER INC的季度营收约是Amphastar Pharmaceuticals, Inc.的1.2倍（$225.2M vs $183.1M），Amphastar Pharmaceuticals, Inc.净利率更高（13.3% vs -375.6%，领先389.0%），PLUG POWER INC同比增速更快（17.6% vs -1.8%），Amphastar Pharmaceuticals, Inc.自由现金流更多（$24.6M vs $-153.0M），过去两年PLUG POWER INC的营收复合增速更高（36.8% vs 3.2%）
安福斯制药是一家上市的美国特种制药企业，公司成立于2004年5月，核心业务为吸入制剂及鼻腔给药产品的研发、生产与销售，聚焦特色医药领域深耕发展。
普拉格能源是一家美国企业，专注于氢燃料电池和电解槽系统的研发，其产品可替代电动设备及车辆所使用的传统电池。公司总部位于纽约州斯林格兰兹，在华盛顿州斯波坎、纽约州罗切斯特均设有生产运营基地。
AMPH vs PLUG — 直观对比
营收规模更大
PLUG
是对方的1.2倍
$183.1M
营收增速更快
PLUG
高出19.5%
-1.8%
净利率更高
AMPH
高出389.0%
-375.6%
自由现金流更多
AMPH
多$177.6M
$-153.0M
两年增速更快
PLUG
近两年复合增速
3.2%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $183.1M | $225.2M |
| 净利润 | $24.4M | $-846.0M |
| 毛利率 | 46.8% | 2.4% |
| 营业利润率 | 19.4% | -338.9% |
| 净利率 | 13.3% | -375.6% |
| 营收同比 | -1.8% | 17.6% |
| 净利润同比 | -35.7% | 36.7% |
| 每股收益（稀释后） | $0.51 | $-0.70 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收AMPHPLUG
| Q4 25 | $183.1M | $225.2M | ||
| Q3 25 | $191.8M | $177.1M | ||
| Q2 25 | $174.4M | $174.0M | ||
| Q1 25 | $170.5M | $133.7M | ||
| Q4 24 | $186.5M | $191.5M | ||
| Q3 24 | $191.2M | $173.7M | ||
| Q2 24 | $182.4M | $143.3M | ||
| Q1 24 | $171.8M | $120.3M |
净利润AMPHPLUG
| Q4 25 | $24.4M | $-846.0M | ||
| Q3 25 | $17.4M | $-361.9M | ||
| Q2 25 | $31.0M | $-227.1M | ||
| Q1 25 | $25.3M | $-196.7M | ||
| Q4 24 | $38.0M | $-1.3B | ||
| Q3 24 | $40.4M | $-211.2M | ||
| Q2 24 | $37.9M | $-262.3M | ||
| Q1 24 | $43.2M | $-295.8M |
毛利率AMPHPLUG
| Q4 25 | 46.8% | 2.4% | ||
| Q3 25 | 51.4% | -67.9% | ||
| Q2 25 | 49.6% | -30.7% | ||
| Q1 25 | 50.0% | -55.3% | ||
| Q4 24 | 46.5% | -122.5% | ||
| Q3 24 | 53.3% | -57.6% | ||
| Q2 24 | 52.2% | -91.6% | ||
| Q1 24 | 52.4% | -132.3% |
营业利润率AMPHPLUG
| Q4 25 | 19.4% | -338.9% | ||
| Q3 25 | 13.2% | -197.0% | ||
| Q2 25 | 24.2% | -101.7% | ||
| Q1 25 | 21.9% | -133.5% | ||
| Q4 24 | 24.2% | -678.7% | ||
| Q3 24 | 29.8% | -124.4% | ||
| Q2 24 | 30.3% | -170.7% | ||
| Q1 24 | 27.9% | -215.7% |
净利率AMPHPLUG
| Q4 25 | 13.3% | -375.6% | ||
| Q3 25 | 9.0% | -204.4% | ||
| Q2 25 | 17.8% | -130.5% | ||
| Q1 25 | 14.8% | -147.1% | ||
| Q4 24 | 20.4% | -697.5% | ||
| Q3 24 | 21.1% | -121.5% | ||
| Q2 24 | 20.8% | -183.0% | ||
| Q1 24 | 25.1% | -245.9% |
每股收益（稀释后）AMPHPLUG
| Q4 25 | $0.51 | $-0.70 | ||
| Q3 25 | $0.37 | $-0.31 | ||
| Q2 25 | $0.64 | $-0.20 | ||
| Q1 25 | $0.51 | $-0.21 | ||
| Q4 24 | $0.74 | $-1.61 | ||
| Q3 24 | $0.78 | $-0.25 | ||
| Q2 24 | $0.73 | $-0.36 | ||
| Q1 24 | $0.81 | $-0.46 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $282.8M | $368.5M |
| 总债务越低越好 | $608.7M | — |
| 股东权益账面价值 | $788.8M | $978.1M |
| 总资产 | $1.6B | $2.6B |
| 负债/权益比越低杠杆越低 | 0.77× | — |
8季度趋势，按日历期对齐
现金及短期投资AMPHPLUG
| Q4 25 | $282.8M | $368.5M | ||
| Q3 25 | $276.2M | $165.9M | ||
| Q2 25 | $231.8M | $140.7M | ||
| Q1 25 | $236.9M | $295.8M | ||
| Q4 24 | $221.6M | $205.7M | ||
| Q3 24 | $250.5M | $93.9M | ||
| Q2 24 | $217.8M | $62.4M | ||
| Q1 24 | $289.6M | $172.9M |
总债务AMPHPLUG
| Q4 25 | $608.7M | — | ||
| Q3 25 | $608.6M | — | ||
| Q2 25 | $607.7M | — | ||
| Q1 25 | $603.9M | — | ||
| Q4 24 | $601.6M | — | ||
| Q3 24 | $596.4M | $3.9M | ||
| Q2 24 | $586.9M | $3.7M | ||
| Q1 24 | $594.0M | $3.8M |
股东权益AMPHPLUG
| Q4 25 | $788.8M | $978.1M | ||
| Q3 25 | $776.7M | $1.4B | ||
| Q2 25 | $757.5M | $1.7B | ||
| Q1 25 | $751.3M | $1.9B | ||
| Q4 24 | $732.3M | $1.7B | ||
| Q3 24 | $727.7M | $3.0B | ||
| Q2 24 | $713.3M | $3.0B | ||
| Q1 24 | $672.4M | $2.9B |
总资产AMPHPLUG
| Q4 25 | $1.6B | $2.6B | ||
| Q3 25 | $1.7B | $3.1B | ||
| Q2 25 | $1.6B | $3.4B | ||
| Q1 25 | $1.6B | $3.6B | ||
| Q4 24 | $1.6B | $3.6B | ||
| Q3 24 | $1.5B | $4.7B | ||
| Q2 24 | $1.5B | $4.8B | ||
| Q1 24 | $1.6B | $4.8B |
负债/权益比AMPHPLUG
| Q4 25 | 0.77× | — | ||
| Q3 25 | 0.78× | — | ||
| Q2 25 | 0.80× | — | ||
| Q1 25 | 0.80× | — | ||
| Q4 24 | 0.82× | — | ||
| Q3 24 | 0.82× | 0.00× | ||
| Q2 24 | 0.82× | 0.00× | ||
| Q1 24 | 0.88× | 0.00× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $32.9M | $-148.6M |
| 自由现金流经营现金流 - 资本支出 | $24.6M | $-153.0M |
| 自由现金流率自由现金流/营收 | 13.4% | -67.9% |
| 资本支出强度资本支出/营收 | 4.5% | 1.9% |
| 现金转化率经营现金流/净利润 | 1.35× | — |
| 过去12个月自由现金流最近4个季度 | $121.2M | $-647.0M |
8季度趋势，按日历期对齐
经营现金流AMPHPLUG
| Q4 25 | $32.9M | $-148.6M | ||
| Q3 25 | $52.6M | $-89.8M | ||
| Q2 25 | $35.6M | $-191.8M | ||
| Q1 25 | $35.1M | $-105.6M | ||
| Q4 24 | $29.0M | $-131.2M | ||
| Q3 24 | $60.0M | $-174.9M | ||
| Q2 24 | $69.1M | $-254.7M | ||
| Q1 24 | $55.3M | $-167.7M |
自由现金流AMPHPLUG
| Q4 25 | $24.6M | $-153.0M | ||
| Q3 25 | $47.2M | $-117.5M | ||
| Q2 25 | $25.0M | $-230.4M | ||
| Q1 25 | $24.4M | $-146.0M | ||
| Q4 24 | $16.6M | $-165.2M | ||
| Q3 24 | $46.2M | $-234.2M | ||
| Q2 24 | $63.1M | $-356.0M | ||
| Q1 24 | $46.5M | $-260.3M |
自由现金流率AMPHPLUG
| Q4 25 | 13.4% | -67.9% | ||
| Q3 25 | 24.6% | -66.4% | ||
| Q2 25 | 14.3% | -132.5% | ||
| Q1 25 | 14.3% | -109.2% | ||
| Q4 24 | 8.9% | -86.3% | ||
| Q3 24 | 24.1% | -134.8% | ||
| Q2 24 | 34.6% | -248.4% | ||
| Q1 24 | 27.1% | -216.5% |
资本支出强度AMPHPLUG
| Q4 25 | 4.5% | 1.9% | ||
| Q3 25 | 2.8% | 15.6% | ||
| Q2 25 | 6.1% | 22.2% | ||
| Q1 25 | 6.3% | 30.3% | ||
| Q4 24 | 6.7% | 17.7% | ||
| Q3 24 | 7.2% | 34.1% | ||
| Q2 24 | 3.3% | 70.7% | ||
| Q1 24 | 5.1% | 77.0% |
现金转化率AMPHPLUG
| Q4 25 | 1.35× | — | ||
| Q3 25 | 3.03× | — | ||
| Q2 25 | 1.15× | — | ||
| Q1 25 | 1.39× | — | ||
| Q4 24 | 0.76× | — | ||
| Q3 24 | 1.48× | — | ||
| Q2 24 | 1.82× | — | ||
| Q1 24 | 1.28× | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
AMPH
| Other Products | $62.4M | 34% |
| Baqsimi | $46.7M | 26% |
| Primatenemist | $27.9M | 15% |
| Epinephrine | $17.1M | 9% |
| Lidocaine | $14.9M | 8% |
| Glucagon | $14.1M | 8% |
PLUG
| Sales Of Equipment And Related Infrastructure | $111.6M | 50% |
| Services Performed On Fuel Cell Systems And Related Infrastructure | $41.5M | 18% |
| Power Purchase Agreements | $36.1M | 16% |
| Sale Of Cryogenic Equipment | $20.0M | 9% |
| Sales Of Fuel Cell Systems | $11.2M | 5% |
| Other | $4.8M | 2% |
